Sign in

CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203435077
Phone
8587318389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. 4 Option exercise See Remarks acquired 3,333 shares (option exercise)
  2. 8-K Event Regulation FD disclosure
  3. SC 13D/A Stake Beneficial Ownership Report
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 4 Open-market buy Director bought 150,000 shares at $1.00 ($149,445)
  6. 8-K Event Regulation FD disclosure
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 8-K Event Executive or director change · Shareholder vote results
  15. 4 Open-market sale 10% owner sold 3,209,316 shares at an average $0.93 ($2,999,056)
  16. 10-Q Report Quarterly Report
  17. 8-K Event Agreement ended · Results of operations · Exit or restructuring costs
  18. 8-K Event Regulation FD disclosure
  19. 3 Insider Initial Statement of Ownership
  20. CT ORDER Other Confidential Order

Page 23 of 38 · 755 filings